KEAP1 and cancer: When cellular oxidative stress is increased, by regulating NRF2 and KEAP1, cancer cells can increase the expression and activity of NRF2 or reduce the binding activity of KEAP1 to stabilize NRF2 and activate downstream antioxidant mechanisms, thereby escaping the toxic effects of anticancer drugs and contributing to the development of cancer.